Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists (Q44356897)

2 December 2017

title

Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists (English)

1 reference

2 December 2017

1 reference

2 December 2017

Salome Steyn

1 reference

2 December 2017

Kay P Castagnoli

1 reference

2 December 2017

Jiang Fan Chen

1 reference

2 December 2017

Michael A Schwarzschild

1 reference

2 December 2017

Cornelis J Van der Schyf

1 reference

2 December 2017

Neal Castagnoli

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Bioorganic & Medicinal Chemistry

2 December 2017

published in

1 reference

2 December 2017

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

1299-1310

1 reference

Neuroprotective therapy for Parkinson's disease

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Inhibition of Monoamine Oxidase Contributes to the Protective Effect of 7‐Nitroindazole Against MPTP Neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Selegiline can mediate neuronal rescue rather than neuronal protection

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-Dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Photo-induced isomerization of 8-(3,4,5-trimethoxystyryl)caffeine as possible route of drug decomposition

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Synthesis and monoamine oxidase B catalyzed oxidation of C-4 heteroaromatic substituted 1,2,3,6-tetrahydropyridine derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Behavioral phenotyping of the MPTP mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Selective inhibitors of monoamine oxidase. 3. Structure-activity relationship of tricyclics bearing imidazoline, oxadiazole, or tetrazole groups

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Inhibition of monoamine oxidase-B by 5H-indeno[1,2-c]pyridazines: biological activities, quantitative structure-activity relationships (QSARs) and 3D-QSARs

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Studies on 1,2,3,6-tetrahydropyridine derivatives as potential monoamine oxidase inactivators

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Preparation of the flavin-containing aromatic amine oxidases of human placenta and beef liver

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900648-X

7 January 2021

10.1016/S0968-0896(02)00648-X

Identifiers

DOI

1 reference

2 December 2017

1 reference